This review highlights the potential of G protein-coupled receptors and their signaling pathways as therapeutic targets for diabetic nephropathy.
Answers are grounded in this paper and cite their sources.
May inform GPCR-targeted therapies in diabetic nephropathy; leaves open prospective clinical validation.
Diabetic nephropathy, a lethal microvascular complication of diabetes mellitus, is characterized by progressive albuminuria, excessive deposition of extracellular matrix, thickened glomerular basement membrane, podocyte abnormalities, and podocyte loss. The G protein-coupled receptors (GPCRs) have attracted considerable attention in diabetic nephropathy, but the specific effects have not been elucidated yet. Likewise, abnormal signaling pathways are closely interrelated to the pathologic process of diabetic nephropathy, despite the fact that the mechanisms have not been explored clearly. Therefore, GPCRs and its mediated signaling pathways are essential for priority research, so that preventative strategies and potential targets might be developed for diabetic nephropathy. This article will give us comprehensive overview of predominant GPCR types, roles, and correlative signaling pathways in diabetic nephropathy.
No takes yet. Share an insight, caveat, or question.
Ding et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: